Masimo Corporation (MASI) and Thoratec Corporation (THOR) are healthcare

firms that focus primarily on the manufacturing and selling of medical devices. Masimo and

Thoratec, both headquartered in the United States, have global operations and sell to hospitals

and clinical sites around the world. Both companies were founded in the 1970-80s with a key

mission of creating rivaled products that will help patients with their health. Though they have

key similarities, the disparities between these two companies are apparent, which will lead

them to prosper in the future. They will both continue to improve, paving the way for incredible

product innovation.

History and Strategy of Masimo & Thoratec:

Masimo Corporation is a medical device company that specializes in non-invasive

patient monitory products, meaning they create products that do not pierce skin, and gets

results from external monitoring. Founded in 1989 by current Chief Executive Officer, Joe Kiani,

Masimo strives to use adaptive signal processing. Key principles and strategies implemented by

Masimo is foremost patient-first. They try and create products to minimize unwarranted

patient deaths and improve lives of both the older population as well as the growing new-born

demographic. Through different product strategies, such as products geared towards

hemoglobin count, or products for monitoring patient hearts and heart detection monitory,

Masimo Corporation is a leader in the field.

Thoratec Corporation is also another company that specializes in medical

technology. The company was found in March of 1976, and subsequently went public 5 years

later in the Spring of 2014. Thoratec’s current executives include Gary F. Burbach (CEO), David

A. Lehman (General Counsel), and Taylor Harris (CFO). Thoratec merged with Thermo

Cardiosystems in February 2001, making it a world leader in the circulatory support space. The

products are geared towards saving, supporting, and restoring